If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElixirr International Regulatory News (ELIX)

Share Price Information for Elixirr International (ELIX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 620.00
Bid: 610.00
Ask: 630.00
Change: -6.00 (-0.96%)
Spread: 20.00 (3.279%)
Open: 620.00
High: 620.00
Low: 615.00
Prev. Close: 626.00
ELIX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Retearn Group Limited

12 Apr 2021 07:00

RNS Number : 0555V
Elixirr International PLC
12 April 2021
 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

Acquisition of Retearn Group Limited

Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, is pleased to announce the acquisition of the entire issued share capital of procurement and transformation firm, The Retearn Group Limited ("Retearn"), for a maximum total consideration payable of approximately £7.0 million plus an additional cash payment based on working capital at completion (the "Acquisition").

 

Highlights

 

· Retearn is a UK-based procurement, transformation and insights consultancy with 35 full-time employees and a broad specialist associate network

· In the year ended 30 June 2020, Retearn recorded revenue of £5.65 million and profit before tax of £0.92 million

· The Acquisition brings specialists in self-funded transformation, and allows Elixirr to meet demand from clients to find savings to fund strategic initiatives

· Demand for cost management and transformation is expected to increase in the next year. In a recent survey by Deloitte, 66% of executives reported that they are likely to pursue cost reduction strategies over the next 12 months, and a further 75% of Fortune 500 companies believe that COVID-19 will accelerate their technological transformation (Fortune Magazine Survey)

· Retearn has an outstanding reputation in the market - its clients rated it 51% higher than the competition and it has been added to the FT's list of the UK's Leading Management Consultants for 2021

· Elixirr's second acquisition since IPO in July 2020 and fully in line with our 'House of Brands' strategy

· Immediately earnings enhancing

 

Consideration for the Acquisition

 

The maximum total consideration payable is £7.0 million. This consists of initial cash consideration of £2.15 million, a proposed issue of 543,939 ordinary shares of 0.005 pence each in the capital of the Company ("Ordinary Shares") at a price of 396 pence per Ordinary Share (being the closing mid-market price of an Ordinary Share on 8 April 2021) equating to an additional £2.15 million, plus potential earn out payments of up to £0.65 million in cash and up to £2.05 million in new Ordinary Shares totalling a maximum of £2.7 million, contingent on Retearn achieving revenue growth and EBITDA margin targets in periods up to 30th June 2024. An additional cash payment will be made based on the working capital of Retearn at completion.

The Ordinary Shares issued pursuant to the Acquisition will be subject to the same restrictions as certain other shareholders of the Company, as described in the Company's IPO admission document. These restrictions consist of a lock-in arrangement until 8 July 2021 and limitations on the Ordinary Shares that each shareholder can sell in each of the following three years.

 

Reasons for the Acquisition

 

Retearn is a UK-based procurement, transformation and insights consultancy which supports clients in driving self-funded transformation initiatives by identifying immediate savings and efficiencies in their cost base. The Acquisition enhances Elixirr's capabilities with specialist expertise and enables Elixirr to meet client demand for rapid cost savings to fund investment in strategic initiatives - increasingly crucial in today's disruptive environment. The Acquisition will be immediately earnings enhancing.

In a recent client survey Retearn was rated 51% higher than their competition. It outperformed the competition in 11 of the 13 categories measured, with its main strengths attributed to return on investment, understanding of client needs and delivery against the project plan.

Retearn was co-founded by Mark Wyllie (CEO), Simon Smith (COO) and Lee Cotsford (CFO) who will continue to lead the business following the Acquisition. On Acquisition, key members of Retearn's management team will receive share options which vest based on achieving future revenue targets.

 

Admission and Total Voting Rights

 

As referred to above, as part of the consideration for the Acquisition, Elixirr has issued 543,939 new Ordinary Shares. Application has been made to the London Stock Exchange for 543,939 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 15 April 2021.

After Admission, the total number of Ordinary Shares in issue will be 46,186,481 and the total number of voting rights will therefore be 46,186,481. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Founder & CEO of Elixirr, Stephen Newton said:

 

"Today I'm delighted to welcome Retearn as the latest addition to Elixirr's House of Brands. The current climate determines an even greater need for business leaders to run efficient operations, whilst the necessity to invest in growth remains paramount. Combining Retearn's expertise in unlocking material savings for businesses with Elixirr's extensive growth and innovation-led capabilities will enable our clients to accelerate investment into their biggest strategic initiatives.

This announcement marks our second acquisition in just over six months as we progress our ambitious growth plans and continue to serve our ultimate goal: to solve our clients' toughest business challenges.

Founded by three ambitious entrepreneurs who are driven by making real change happen for clients, Retearn echoes Elixirr's ethos entirely. I'm excited to see what the future holds for the House of Brands as we continue to maintain our passion for client success whilst widening the breadth of our service offering."

 

CEO of Retearn, Mark Wyllie said:

 

"We were ready for our next phase of growth and Elixirr's unique House of Brands offers the perfect platform for this. We can maintain the brand that's made Retearn what it is today, whilst benefitting from the value and expertise of the collective Elixirr Companies to create lasting change for our clients. Being part of Elixirr is also a brilliant opportunity for our staff to further develop their skillsets and careers.

We are excited for what the future holds and look forward to the next chapter of our story as part of the House of Brands!"

 

For further Information please contact:

Elixirr International plc

Stephen Newton, CEO

Graham Busby, CFO

 

 

 

 

Public and Investor Relations contacts:

Caroline Pitt

 

 

finnCap Ltd (Nominated Adviser & Sole Broker)

Christopher Raggett, Simon Hicks, Kate Bannatyne (Corporate Finance)

Alice Lane, Sunila De Silva (ECM)

 

 

 

investor-relations@elixirr.com

 

 

+44 (0)20 7220 0500

 

 

 

   

About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSFAFFSEFSEIL
12
Date   Source Headline
24th Apr 20247:00 amRNSGrant of Share Options
22nd Apr 20247:00 amRNSFinal Results
8th Apr 20247:00 amRNSNotice of FY 23 Results and Investor Presentation
26th Jan 20247:00 amRNSDirector Dealing
8th Jan 20247:00 amRNSTrading Update and Change to Dividend Policy
11th Dec 20237:00 amRNSAcquisition of Insigniam LLC and Insigniam SAS
18th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSAcquisition of Responsum, Inc.
13th Jun 202310:45 amRNSResult of AGM
24th May 20231:31 pmRNSHolding(s) in Company
19th May 20237:00 amRNSPosting of Annual Report and Accounts
10th May 20233:00 pmRNSDirector/PCA Dealings
26th Apr 20237:00 amRNSGrant of Share Options
12th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20233:00 pmRNSDirector Dealing
3rd Apr 20239:15 amRNSDirector Dealing
3rd Apr 20237:00 amRNSFinal Results
28th Mar 20237:00 amRNSInvestor Presentation
27th Feb 20239:05 amRNSSecond Price Monitoring Extn
27th Feb 20239:00 amRNSPrice Monitoring Extension
27th Feb 20237:00 amRNSTrading Update
24th Feb 20232:05 pmRNSSecond Price Monitoring Extn
24th Feb 20232:00 pmRNSPrice Monitoring Extension
24th Feb 202311:05 amRNSSecond Price Monitoring Extn
24th Feb 202311:00 amRNSPrice Monitoring Extension
29th Nov 20221:15 pmRNSInvestor Presentation
11th Nov 20227:00 amRNSDirector Dealing
20th Oct 20227:00 amRNSPCA Dealing
6th Oct 20227:00 amRNSPurchase of Shares by Employee Benefit Trust
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:35 pmRNSPrice Monitoring Extension
11th Jul 20221:45 pmRNSPDMR/PCA Dealing
7th Jul 202211:15 amRNSPCA Dealing
13th Jun 20221:00 pmRNSResult of AGM
19th May 20227:00 amRNSPosting of Annual Report & Accounts
29th Apr 20224:07 pmRNSResult of Secondary Placing
28th Apr 20224:06 pmRNSProposed Secondary Placing
8th Apr 20224:15 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSAcquisition of iOLAP and FY2022 Earnings
1st Feb 20227:00 amRNSTrading Update
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 202111:41 amRNSResult of Secondary Placing
13th Oct 20217:00 amRNSProposed Secondary Placing
27th Sep 20217:00 amRNSInterim Results
17th Jun 20218:13 amRNSDirector/PDMR Shareholding
16th Jun 202112:21 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.